ClinVar Miner

Submissions for variant NM_000548.5(TSC2):c.1716+1G>A

dbSNP: rs45517190
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002399402 SCV002712315 pathogenic Hereditary cancer-predisposing syndrome 2019-09-24 criteria provided, single submitter clinical testing The c.1716+1G>A intronic pathogenic mutation results from a G to A substitution one nucleotides after coding exon 15 of the TSC2 gene. This variant has been identified in one individual with tuberous sclerosis complex (TSC) (Ambry internal data). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation.
GeneDx RCV003332096 SCV004040334 likely pathogenic not provided 2023-03-25 criteria provided, single submitter clinical testing Canonical splice site variant expected to result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown.; Deletions involving coding exons of this gene are a known mechanism of disease (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); Also known as IVS15+1G>A; This variant is associated with the following publications: (PMID: 17304050)
Tuberous sclerosis database (TSC2) RCV000043415 SCV000067221 not provided Tuberous sclerosis syndrome no assertion provided curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.